{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:08:30Z","timestamp":1760054910702,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.respe.2018.08.006","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T13:44:13Z","timestamp":1539006253000},"page":"385-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diversit\u00e9 des prises en charge des patients atteints de scl\u00e9rose en plaques entre r\u00e9gions fran\u00e7aises"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0900-8351","authenticated-orcid":false,"given":"C.","family":"Blein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Chamoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Lepage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"AFSEP. Paris\u00a0; 2017","key":"10.1016\/j.respe.2018.08.006_bib0220"},{"issue":"2","key":"10.1016\/j.respe.2018.08.006_bib0225","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.praneu.2015.01.013","article-title":"Scl\u00e9rose en plaques\u00a0: pr\u00e9valence de la neurod\u00e9g\u00e9n\u00e9rescence","volume":"6","author":"Vermersch","year":"2015","journal-title":"Pratique Neurol"},{"year":"2017","series-title":"ARSEP Fondation. Paris\u00a0: 2017","key":"10.1016\/j.respe.2018.08.006_bib0230"},{"issue":"1","key":"10.1016\/j.respe.2018.08.006_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2010.09.005","article-title":"Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis","volume":"93","author":"Dutta","year":"2011","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.respe.2018.08.006_bib0240","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1749-6632.1965.tb20235.x","article-title":"Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis","volume":"122","author":"Schumacher","year":"1965","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"10.1016\/j.respe.2018.08.006_bib0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.respe.2018.08.006_bib0250","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","article-title":"Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis","volume":"120","author":"Barkhof","year":"1997","journal-title":"Brain J Neurol"},{"issue":"12","key":"10.1016\/j.respe.2018.08.006_bib0255","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/WNL.38.12.1822","article-title":"Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis","volume":"38","author":"Fazekas","year":"1988","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.respe.2018.08.006_bib0260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1212\/WNL.60.1.27","article-title":"New diagnostic criteria for multiple sclerosis: application in first demyelinating episode","volume":"60","author":"Tintor\u00e9","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.respe.2018.08.006_bib0265","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/1531-8249(200006)47:6<831::AID-ANA21>3.0.CO;2-H","article-title":"Diagnostic criteria for primary progressive multiple sclerosis: a position paper","volume":"47","author":"Thompson","year":"2000","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.respe.2018.08.006_bib0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.respe.2018.08.006_bib0275","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005\u00a0revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.respe.2018.08.006_bib0280","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017\u00a0revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.respe.2018.08.006_bib0285","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.nic.2008.09.002","article-title":"The clinical epidemiology of multiple sclerosis","volume":"18","author":"Confavreux","year":"2008","journal-title":"Neuroimaging Clin N Am"},{"issue":"3","key":"10.1016\/j.respe.2018.08.006_bib0290","first-page":"191","article-title":"Scl\u00e9rose en plaques\u00a0: adapter le parcours de soins \u00e0 l\u2019h\u00e9t\u00e9rog\u00e9n\u00e9it\u00e9 des chemins cliniques","volume":"137","author":"Lubetzki","year":"2015","journal-title":"Concours Med"},{"issue":"1","key":"10.1016\/j.respe.2018.08.006_bib0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","article-title":"The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration","volume":"52","author":"Hauser","year":"2006","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.respe.2018.08.006_bib0300","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013\u00a0revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.respe.2018.08.006_bib0305","doi-asserted-by":"crossref","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","article-title":"Multiple sclerosis: geoepidemiology, genetics and the environment","volume":"9","author":"Milo","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.respe.2018.08.006_bib0310","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neurol.2009.04.003","article-title":"Epidemiology of multiple sclerosis: the special situation in France","volume":"165","author":"Fromont","year":"2009","journal-title":"Rev Neurol"},{"key":"10.1016\/j.respe.2018.08.006_bib0315","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.lpm.2009.11.008","article-title":"Natural history of multiple sclerosis","volume":"39","author":"Vukusic","year":"2010","journal-title":"Presse Med"},{"issue":"1","key":"10.1016\/j.respe.2018.08.006_bib0320","first-page":"S17","article-title":"Pr\u00e9valence de la scl\u00e9rose en plaques en France en 2012\u00a0et mortalit\u00e9 associ\u00e9e en 2013\u00a0\u00e0 partir des donn\u00e9es du SNIIRAM-PMSI","volume":"63","author":"Foulon","year":"2016","journal-title":"Rev Epidemio Sante Publique"},{"issue":"6","key":"10.1016\/j.respe.2018.08.006_bib0325","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00415-017-8513-0","article-title":"Prevalence and mortality of patients with multiple sclerosis in France in 2012: a study based on French health insurance data","volume":"264","author":"Foulon","year":"2017","journal-title":"J Neurol"},{"year":"2015","series-title":"Minist\u00e8re des affaires sociales et de la sant\u00e9. Paris\u00a0: 2015","key":"10.1016\/j.respe.2018.08.006_bib0330"},{"year":"2017","series-title":"AMELI. Paris\u00a0: 2017","key":"10.1016\/j.respe.2018.08.006_bib0335"},{"year":"2007","series-title":"La prise en charge de votre maladie, la scl\u00e9rose en plaques. Vivre avec une scl\u00e9rose en plaques","author":"Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.respe.2018.08.006_bib0340"},{"year":"2014","series-title":"Plan maladies neurod\u00e9g\u00e9n\u00e9ratives 2014\u20132019","key":"10.1016\/j.respe.2018.08.006_bib0345"},{"key":"10.1016\/j.respe.2018.08.006_bib0350","unstructured":"R\u00e9publique Fran\u00e7aise. Circulaire SG\/DGOS\/R4\/DGS\/MC3\/DGCS\/3A\/CNSA no 2015-281\u00a0du 7\u00a0septembre 2015\u00a0relative \u00e0 la mise en \u0153uvre du plan maladies neurod\u00e9g\u00e9n\u00e9ratives 2014\u20132019. NOR\u00a0: AFSZ1521300C. [Disponible sur\u00a0: https:\/\/solidarites-sante.gouv.fr\/fichiers\/bo\/2015\/15-09\/ste_20150009_0000_0056.pdf]"},{"key":"10.1016\/j.respe.2018.08.006_bib0355","unstructured":"R\u00e9publique Fran\u00e7aise. Circulaire No DGOS\/R1\/2015\/332\u00a0du 30\u00a0octobre 2015\u00a0relative \u00e0 la campagne tarifaire et budg\u00e9taire 2015\u00a0des \u00e9tablissements de sant\u00e9. NOR AFSH1526700C. [Disponible sur\u00a0: https:\/\/solidarites-sante.gouv.fr\/fichiers\/bo\/2015\/15-12\/ste_20150012_0000_0079.pdf]"},{"key":"10.1016\/j.respe.2018.08.006_bib0360","unstructured":"R\u00e9publique Fran\u00e7aise. Circulaire No DGOS\/R1\/2016\/172\u00a0du 12\u00a0mai 2016\u00a0relative \u00e0 la campagne tarifaire et budg\u00e9taire 2016\u00a0des \u00e9tablissements de sant\u00e9. NOR AFSH1614309C. [Disponible sur\u00a0: https:\/\/solidarites-sante.gouv.fr\/fichiers\/bo\/2016\/16-07\/ste_20160007_0000_0085.pdf]"},{"key":"10.1016\/j.respe.2018.08.006_bib0365","unstructured":"R\u00e9publique Fran\u00e7aise. Instruction No DGOS\/R4\/2016\/176\u00a0du 27\u00a0mai 2016\u00a0relative aux modalit\u00e9s de labellisation des Centres de ressources et de comp\u00e9tences SEP. NOR\u00a0: AFSH1618442J. [Disponible sur\u00a0: https:\/\/solidarites-sante.gouv.fr\/fichiers\/bo\/2016\/16-08\/ste_20160008_0000_0033.pdf]"},{"year":"2014","series-title":"Mode d\u2019emploi du plan personnalis\u00e9 de sant\u00e9 (PPS) pour les personnes \u00e0 risque de perte d\u2019autonomie (PAERPA)","author":"Haute Autorit\u00e9 de sant\u00e9","key":"10.1016\/j.respe.2018.08.006_bib0370"},{"year":"2016","series-title":"Guide m\u00e9thodologique de production des informations relatives \u00e0 l\u2019activit\u00e9 m\u00e9dicale et \u00e0 sa facturation en m\u00e9decine, chirurgie, obst\u00e9trique et odontologie","key":"10.1016\/j.respe.2018.08.006_bib0375"},{"issue":"W18","key":"10.1016\/j.respe.2018.08.006_bib0380","first-page":"A54","article-title":"Consommations de soins des patients atteints de scl\u00e9rose en plaques en France de 2007\u00a0\u00e0 2013\u00a0\u00e0 partir des bases de donn\u00e9es m\u00e9dico administratives","volume":"I172S","author":"Roux","year":"2016","journal-title":"Rev Neurol"},{"issue":"1","key":"10.1016\/j.respe.2018.08.006_bib0385","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/j.respe.2016.01.061","article-title":"Utilisation des bases m\u00e9dico-administratives pour l\u2019\u00e9tude des parcours de soins des patients atteints de scl\u00e9rose en plaques en France de 2007\u00a0\u00e0 2013","volume":"64","author":"Roux","year":"2016","journal-title":"Rev Epidemiol Sante Publique"},{"year":"2015","series-title":"Aide \u00e0 l\u2019utilisation des informations de cha\u00eenage","key":"10.1016\/j.respe.2018.08.006_bib0390"},{"key":"10.1016\/j.respe.2018.08.006_bib0395","unstructured":"R\u00e9publique Fran\u00e7aise. Arr\u00eat\u00e9 du 4\u00a0mars 2016\u00a0fixant pour l\u2019ann\u00e9e 2016\u00a0les \u00e9l\u00e9ments tarifaires mentionn\u00e9s aux I et IV de l\u2019article L. 162-22-10\u00a0du code de la s\u00e9curit\u00e9 sociale. NOR\u00a0: AFSH1606596A. [Disponible sur\u00a0: https:\/\/www.legifrance.gouv.fr\/affichTexte.do?cidTexte=JORFTEXT000032165030&categorieLien=cid]"},{"key":"10.1016\/j.respe.2018.08.006_bib0400","unstructured":"R\u00e9publique Fran\u00e7aise. Arr\u00eat\u00e9 du 25\u00a0f\u00e9vrier 2016\u00a0modifiant l\u2019arr\u00eat\u00e9 du 19\u00a0f\u00e9vrier 2015\u00a0relatif aux forfaits allou\u00e9s aux \u00e9tablissements de sant\u00e9 mentionn\u00e9s \u00e0 l\u2019article L. 162-22-6\u00a0du code de la s\u00e9curit\u00e9 sociale ayant des activit\u00e9s de m\u00e9decine, chirurgie, obst\u00e9trique et odontologie ou ayant une activit\u00e9 d\u2019hospitalisation \u00e0 domicile. NOR\u00a0: AFSH1605920A. [Disponible sur\u00a0: https:\/\/www.legifrance.gouv.fr\/affichTexte.do?cidTexte=LEGITEXT000032135520]."},{"year":"2017","series-title":"Indicateurs d\u00e9mographiques population au 1er janvier 2015","author":"ECO sant\u00e9","key":"10.1016\/j.respe.2018.08.006_bib0415"},{"year":"2016","series-title":"D\u00e9mographie des professions de sant\u00e9","author":"ECO sant\u00e9","key":"10.1016\/j.respe.2018.08.006_bib0410"},{"issue":"7","key":"10.1016\/j.respe.2018.08.006_bib0420","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archneur.63.7.1001","article-title":"Type 1\u00a0diabetes and multiple sclerosis: a Danish population-based cohort study","volume":"63","author":"Nielsen","year":"2006","journal-title":"Arch Neurol"},{"year":"2012","series-title":"Epid\u00e9miologie de la scl\u00e9rose en plaques en France","author":"Fromont","key":"10.1016\/j.respe.2018.08.006_bib0425"},{"issue":"3","key":"10.1016\/j.respe.2018.08.006_bib0210","article-title":"Healthcare expenditure of multiple sclerosis patients in 2013: a nationwide study based on French health administrative databases","volume":"3","author":"Lefeuvre","year":"2017","journal-title":"Mult Scler J Exp Transl Clin"},{"issue":"W09","key":"10.1016\/j.respe.2018.08.006_bib0405","first-page":"A54","article-title":"Co\u00fbt de la scl\u00e9rose en plaques en France\u00a0: description des diff\u00e9rents postes de d\u00e9penses \u00e0 partir des bases de donn\u00e9es de l\u2019assurance maladie","volume":"I172S","author":"Lefeuvre","year":"2016","journal-title":"Rev Neurol"}],"container-title":["Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762018313440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0398762018313440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:40:46Z","timestamp":1759970446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0398762018313440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0398762018313440"],"URL":"https:\/\/doi.org\/10.1016\/j.respe.2018.08.006","relation":{},"ISSN":["0398-7620"],"issn-type":[{"type":"print","value":"0398-7620"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diversit\u00e9 des prises en charge des patients atteints de scl\u00e9rose en plaques entre r\u00e9gions fran\u00e7aises","name":"articletitle","label":"Article Title"},{"value":"Revue d'\u00c9pid\u00e9miologie et de Sant\u00e9 Publique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.respe.2018.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}